Bausch Health Companies Inc. Employee Count
The employee counts Bausch Health Companies Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 20,300; Filing 2026-02-19; Lease expense per employee $5,123.15.
- 2024-12-31: Employees (as filed) 20,700; Filing 2025-02-20; Lease expense per employee $4,589.37.
- 2023-12-31: Employees (as filed) 20,270; Filing 2024-02-22; Lease expense per employee $3,996.05.
- 2022-12-31: Employees (as filed) 19,900; Filing 2023-02-23; Lease expense per employee $3,869.35.
- Available history
- 2009-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 20,300 | 2026-02-19 | $5,123.15 operating + variable + short-term |
| 2024-12-31 | 20,700 | 2025-02-20 | $4,589.37 operating + variable + short-term |
| 2023-12-31 | 20,270 | 2024-02-22 | $3,996.05 operating + variable + short-term |
| 2022-12-31 | 19,900 | 2023-02-23 | $3,869.35 operating + variable + short-term |
| 2021-12-31 | 19,600 full-time | 2022-02-23 | $4,030.61 operating + variable + short-term |
| 2020-12-31 | 21,600 | 2021-02-24 | $3,564.81 operating + variable + short-term |
| 2019-12-31 | 21,700 | 2020-02-19 | $3,594.47 operating + variable + short-term |
| 2018-12-31 | 21,100 | 2019-02-20 | $4,360.19 rent expense, net |
| 2017-12-31 | 20,700 | 2018-02-28 | $4,927.54 rent expense, net |
| 2016-12-31 | 21,500 | 2017-03-01 | $4,790.70 rent expense, net |
| 2015-12-31 | 22,000 | 2016-04-29 | $3,863.64 rent expense, net |
| 2014-12-31 | 16,800 | 2015-02-25 | $4,464.29 rent expense, net |
| 2013-12-31 | 17,200 | 2014-02-28 | $3,023.26 rent expense, net |
| 2011-12-31 | 6,900 | 2012-02-29 | $2,623.19 rent expense, net |
| 2010-12-31 | 4,300 | 2011-02-28 | $2,837.21 rent expense, net |
| 2009-12-31 | 1,291 | 2010-02-26 | $3,718.05 rent expense, net |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |